ibopamine has been researched along with Autoimmune Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benzi, L; Cecchetti, P; Ciccarone, AM; Cicchetti, V; Di Cianni, G; Navalesi, R; Sabino, F | 1 |
1 trial(s) available for ibopamine and Autoimmune Diabetes
| Article | Year |
|---|---|
Ibopamine does not affect insulin resistance in patients with type I diabetes.
Topics: Adult; Blood Glucose; Cardiotonic Agents; Deoxyepinephrine; Diabetes Mellitus, Type 1; Female; Heart Failure; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Vasodilator Agents | 1990 |